Plavix Patent Litigation to Resume, Sanofi Exec Says
Patent litigation between Sanofi-Aventis S.A., Bristol-Myers Squibb and Apotex Corp. over a generic version of the blood thinner Plavix will be reinstated, Sanofi Chief Financial Officer Jean-Claude Leroy said on Wednesday....To view the full article, register now.
Already a subscriber? Click here to view full article